Form 10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

0001193125-21-271530.txt : 20210913 0001193125-21-271530.hdr.sgml : 20210913 20210913164540 ACCESSION NUMBER: 0001193125-21-271530 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 39 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210913 DATE AS OF CHANGE: 20210913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III CENTRAL INDEX KEY: 0001842939 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40228 FILM NUMBER: 211250196 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-494-3296 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 10-Q 1 d211732d10q.htm FORM 10-Q Form 10-Q

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Alpha Healthcare Acquisition Corp. III

(Exact name of registrant as specified in its charter)


Delaware	001 - 40228	86-1645738
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (646)

494-3296

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant	ALPAU	The Nasdaq Stock Market LLC
Class A Common Stock, par value $0.0001 per share	ALPA	The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50	ALPAW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes

☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of

Regulation S-T (§232.405

of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes

☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated

filer, a non-accelerated filer, a

smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth

company” in Rule 12b-2 of the

Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as

defined in Rule 12b-2 of the

Exchange Act). Yes ☒ No ☐

of September 13, 2021

15,000,000 Class A common stock, par value $0.0001, and 4,312,500 Class B common stock, par value $0.0001, were issued and outstanding.

Table of Contents

Alpha Healthcare Acquisition Corp. III

Quarterly Report

on Form 10-Q

Table of Contents


		Page No.

	PART I. FINANCIAL INFORMATION

Item 1.	Unaudited Condensed Financial Statements		1

	Unaudited Condensed Balance Sheet		1

	Unaudited Condensed Statements of Operations		2

	Unaudited Condensed Statements of Changes in Stockholders’ Equity		3

	Unaudited Condensed Statement of Cash Flows		4

	Notes to Unaudited Condensed Financial Statements		5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		15

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		18

Item 4.	Controls and Procedures		18

	PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		19

Item 1A.	Risk Factors		19

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		19

Item 3.	Defaults Upon Senior Securities		19

Item 4.	Mine Safety Disclosures		19

Item 5.	Other Information		19

Item 6.	Exhibits		20

SIGNATURES			22

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Condensed Financial Statements

ALPHA HEALTHCARE ACQUISITION CORP. III

CONDENSED BALANCE SHEET

(Unaudited)


	June 30, 2021
Assets
Deferred offering costs	$	315,178

Total assets	$	315,178

Liabilities and Stockholders’ Equity
Current liabilities:
Accrued offering costs and expenses	$	240,934
Due to related party		56,820

Total current liabilities		297,754

Commitments and Contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding		—
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 4,312,500 shares issued and outstanding (1)		431
Additional paid-in capital		24,569
Accumulated deficit		(7,576	)

Total stockholders’ equity		17,424

Total Liabilities and Stockholder’s Equity	$	315,178

(1)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ALPHA HEALTHCARE ACQUISITION CORP. III

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)


	For the Three Months Ended June 30, 2021			For the period from January 21, 2021 (inception) through June 30, 2021
Formation cost	$	—			1,211
Other expenses		6,365			6,365

Net loss		(6,365	)		(7,576	)

Basic and diluted weighted average shares outstanding (1)		3,750,000			3,750,000

Basic and diluted net loss per share	$	(0.00	)		(0.00	)

(1)

This share quantity excludes up to 562,500 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On March 1, 2021, the Company effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split.

See accompanying notes to the financial statements.

Table of Contents

ALPHA HEALTHCARE ACQUISITION CORP. III

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER’S EQUITY

FOR THE PERIOD FROM JANUARY 21, 2021 (INCEPTION) THROUGH JUNE 30, 2021

AND FOR THE PERIOD FROM JANUARY 21, 2021 (INCEPTION) THROUGH MARCH 31, 2021

(Unaudited)


	Class B common stock				Additional Paid-in Capital		Accumulated Deficit			Total Stockholder’s Equity
	Shares (1)		Amount		Additional Paid-in Capital		Accumulated Deficit			Total Stockholder’s Equity
Balance as of January 21, 2021		—	$	—	$	—	$	—		$	—
Class B common stock issued to Sponsor		4,312,500		431		24,569		—			25,000
Net loss		—		—		—		(1,211	)		(1,211	)

Balance as of March 31, 2021		4,312,500	$	431	$	24,569	$	(1,211	)	$	23,789
Net loss		—		—		—		(6,365	)		(6,365	)

Balance as of June 30, 2021		4,312,500	$	431	$	24,569	$	(7,576	)	$	17,424

(1)

See accompanying notes to the financial statements.

Table of Contents

ALPHA HEALTHCARE ACQUISITION CORP. III

CONDENSED STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM JANUARY 21, 2021 (INCEPTION) THROUGH JUNE 30, 2021

(Unaudited)


Cash Flows from Operating Activities:
Net loss	$	(7,576	)
Changes in current assets and current liabilities:
Accrued offerings costs and expenses		1,211
Net cash used in operating activities		(6,365	)

Cash Flows from Financing Activities:
Proceeds from related party		56,820
Payments of offering costs		(50,455	)

Net cash provided by financing activities		6,365
Net Change in Cash		—
Cash - January 21, 2021 (inception)		—

Cash - end of the period	$	—

Supplemental Disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock	$	25,000

Deferred offering costs included in accrued offerings costs and expenses	$	239,723

See accompanying notes to the financial statements.

Table of Contents

ALPHA HEALTHCARE ACQUISITION CORP. III

NOTES TO FINANCIAL STATEMENTS

Note 1 — Organization and Business Operations

Alpha Healthcare Acquisition Corp. III is a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target. While the Company may pursue an initial Business Combination target in any business or industry, it intends to focus its search on companies in the healthcare industry.

The Company has selected December 31 as its fiscal year end.

As of June 30, 2021, the Company had not yet commenced any operations. All activity from January 21, 2021 (inception) through June 30, 2021, relates to the Company’s formation and the Public Offering (as defined below).

The registration statement for the Company’s Public Offering was declared effective on July 26, 2021. On July 29, 2021 (“IPO Date”), the Company consummated the Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $150,000,000, which is described in Note 3. In connection with the IPO, the Company also granted the underwriters a

45-day

option to purchase an additional 2,250,000 Public Units at the initial public offering price.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 455,000 Units (each, a “Private Placement Unit” and, collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to AHAC Sponsor III LLC (the “Sponsor”), generating gross proceeds of $4,550,000, which is described in Note 4.

At the IPO Date, transaction costs amounted to $3,353,143, consisting of $3,000,000 of underwriting fees and $353,143 of other offering costs. The Company has also accrued underwriting fees of $5,250,000 that will be paid only if a business combination is entered into. In addition, cash of $1,550,000 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes.

On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030. Resulting from the partial over-allotment exercise, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds.

Following the closing of the Initial Public Offering on July 29, 2021, an amount of $154,441,030 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, including the Units sold upon the exercise of the over-allotment option, and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule

2a-7

of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. Except for the withdrawal of interest income to pay the income taxes, the Company’s amended and restated certificate of incorporation and subject to the requirements of law and regulation, provides that none of the funds held in the Trust Account will be released from the Trust Account until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of the public shares if the Company is unable to consummate an initial Business Combination within 24 months from the closing of the Public Offering (the “Combination Period”), subject to applicable law, and (c) the redemption of the Company’s public shares properly submitted in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or

pre-initial

Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.

Table of Contents

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination.

The Company’s Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the interest earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete an initial Business Combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest (net of taxes payable), divided by the number of then outstanding public shares. The amount in the Trust Account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters.

The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

The Sponsor has agreed (i) to waive its redemption rights with respect to any Founder Shares, private placement shares and public shares held by it in connection with the completion of the initial Business Combination, (ii) to waive its rights to liquidating distributions from the Trust Account with respect to any Founder Shares or private placement shares held by it if the Company fails to complete its Business Combination within the Combination Period, although the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any public shares it holds if the Company fails to complete its Business Combination within such time period, (iii) not to propose any amendment to the Company’s amended and restated certificate of incorporation that would modify the substance or timing of its obligation to redeem 100% of the public shares if the Company does not complete its initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or

pre-initial

Business Combination activity, unless the Company provides its public stockholders with the opportunity to redeem their shares, and (iv) to vote any Founder Shares held by it and any public shares purchased during or after the Public Offering in favor of the Company’s initial Business Combination.

Table of Contents

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per share due to reductions in the value of the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Going Concern Consideration

Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period or time, which is considered to be one year from the issuance date of the condensed financial statements. On July 29, 2021, the Company consummated its Initial Public Offering at which time capital in excess of the funds deposited in the trust and/or used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date these financials are issued and therefore substantial doubt has been alleviated.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and Article 8 of Regulation

S-X

of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 27, 2021, as well as the Company’s Current Reports on Form

8-K,

as filed with the SEC on July 29, 2021 and August 4, 2021. The interim results for the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.

Table of Contents

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Offering Costs

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Offering costs amounted to $315,178 at June 30, 2021, which were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

Table of Contents

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The provision for income taxes was deemed to be de minimis for the period from January 21, 2021 (inception) through June 30, 2021.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Derivative Instruments

The Company issues warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC

815-40,

including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification.

At the IPO Date, the Public Warrants (see Note 3) and Private Warrants (see Note 4) were accounted for as equity as these instruments meet all of the requirements for equity classification under ASC

815-40.

Recently Issued Accounting Standards

In August 2020, the FASB issued ASU

No. 2020-06,

Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”),

which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and certain criteria under ASC 840 that is used to determine whether a derivative financial instrument meets the additional criteria necessary for equity classification. ASU

2020-06

allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this change will have on its financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company’s financial statements.

Note 3 — Initial Public Offering

On July 29, 2021, the Company sold 15,000,000 Units at $10.00 per Unit, generating gross proceeds of $150.0 million. Each unit consists of one share of Class A common stock and

one-fourth

of one redeemable warrant. Only whole warrants are exercisable. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share.

Table of Contents

On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030, received on August 6, 2021. Resulting from the partial over-allotment exercise, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds.

Note 4 — Related Party Transactions

Founder Shares

On January 21, 2021, the Sponsor subscribed to purchase 3,593,750 shares of the Company’s common stock, par value $0.0001 per share (the “Founder Shares”) for an aggregate price of $25,000. On January 25, 2021, the Sponsor paid $25,000, or approximately $0.00696 per share, to cover for certain offering and formation costs in consideration for 3,593,750 Founder Shares. On March 1, 2021, the Company effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units out of the total 2,250,000 available under the over-allotments and the forfeiture provisions lapsed for 111,026 Founder Shares. The remaining 451,464 Founder Shares were forfeited upon the expiration of the

45-day

period reserved for the exercise of over-allotment option.

The Sponsor, directors and executive officers have agreed not to transfer, assign or sell (i) any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company’s shares of Class A common stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150

days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of its public stockholders having the right to exchange their common stock for cash, securities or other property, and (ii) any of their Private Placement Units, placement shares, Private Placement Warrants and Class A common stock issued upon conversion or exercise thereof until 30 days after the completion of the initial Business Combination (the

“Lock-up”).

Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and directors and executive officers with respect to any Founder Shares, Private Placement Units, placement shares, Private Placement Warrants and Class A common stock issued upon conversion or exercise thereof.

Private Placement

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 455,000 Private Placement Units for an aggregate purchase price of $4,550,000, in a private placement. Each Private Placement Unit is identical to the Units sold in the Initial Public Offering except as described below. A portion of the proceeds from the Private Placement Units was added to the proceeds from the Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

Resulting from the partial over-allotment exercise on August 3, 2021, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds.

The Private Placement Units (including the placement shares, the placement warrants and Class A common stock issuable upon exercise of such placement warrants) will not be transferable or salable until 30 days after the completion of our Business Combination (except, among other limited exceptions, to our officers and directors and other persons or entities affiliated with our Sponsor).

Table of Contents

Promissory Note — Related Party

On January 25, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 to be used for a portion of the expenses of the Proposed Public Offering. This loan is

non-interest

bearing, unsecured, and due at the earlier of (i) the date on which the Company consummates the initial public offering and (ii) the date on which the Company determines not to conduct an initial public offering of its securities, upon request from the Company the Sponsor. The loan will be repaid upon the closing of the Proposed Public Offering out of the offering proceeds not held in the Trust Account. As of June 30, 2021, the Company had no borrowings outstanding under the promissory note.

Due to Related Party

The balance of $56,820 as of June 30, 2021, of which $50,455 represents the offering costs paid by the Sponsor on behalf of the Company.

Administrative Service Fee

The Company has agreed, commencing on the date that the Company’s securities are first listed on the Nasdaq, to pay an affiliate of the Sponsor a monthly fee of an aggregate of $10,000 for office space, administrative and support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.50 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2021, there were no written agreements in place for the Working Capital Loans..

Note 5 — Commitments & Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Units, Private Placement Warrants, Class A common stock underlying the Private Placement Warrants and Private Placement Units that may be issued upon conversion of Working Capital Loans (and any shares or Class A common stock issuable upon the exercise of the Private Placement Warrants and Private Placement Units that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement dated July 26, 2021. The holders of these securities are entitled to make unlimited demands that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable

lock-up

period, which occurs (i) in the case of the Founder Shares, as described in the following paragraph, and (ii) in the case of the Private Placement Warrants and the respective shares of Class A common stock underlying such warrants, 30 days after the completion of the Company’s initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Table of Contents

Underwriters Agreement

The Company granted the underwriters a

45-day

option from July 26, 2021, to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030.

The underwriters received a cash underwriting discount of two percent (2.0%) of the gross proceeds of the Public Offering, or $3,000,000 (or up to $3,450,000 if the underwriters’ over-allotment is exercised in full), paid on July 29, 2021. In addition, the underwriters will be entitled to a deferred underwriting fee of three and a half percent (3.5%), or $5,250,000 of the gross proceeds of the Public Offering (or up to $6,037,500 if the underwriters’ over-allotment is exercised in full) upon the completion of the Company’s initial Business Combination.

Risks and Uncertainties

Management is currently evaluating the impact of the

COVID-19

pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 6 — Stockholder’s Equity

Common Stock

— On January 25, 2021, the Company issued 3,593,750 shares of common stock, including an aggregate of up to 468,750 shares of common stock that were subject to forfeiture, to the Company by the initial stockholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial stockholders will collectively own 20% of the Company’s issued and outstanding common stock after the Proposed Public Offering.

On March 1, 2021, the Company amended its charter to authorize issuance of 100,000,000 Class A common stock, with a par value of $0.0001 per share, 10,000,000 Class B common stock, with a par value of $0.0001 per share, and 1,000,000 preferred stock, with a par value of $0.0001 per share, and effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding All shares and per share amounts have been retroactively restated to reflect the stock split.

At June 30, 2021, there were (i) no shares of Class A common stock issued and outstanding and (ii) 4,312,500 shares of Class B common stock issued and outstanding, of which an aggregate of up to 562,500 shares of Class B common stock were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units out of the total 2,250,000 available under the over-allotments and the forfeiture term lapsed for 111,026 Founder Shares. The remaining 451,464 Founder Shares were forfeited upon the expiration of the

45-day

period reserved for the exercise of over-allotment option.

Both Class A and B stockholders will vote together as a single class on all matters submitted to a vote of the Company stockholders, with each share of common stock entitling the holder to one vote.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a

one-for-one

basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless our Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an

as-converted

basis, 20% of the sum of the total number of all shares of common stock

Table of Contents

outstanding upon completion of the Proposed Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders) (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination and any Private Placement Units issued to our Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

Preferred Stock

– The Company is authorized to issue 1,000,000 shares of preferred stock, with a par value of $0.0001 per share. At June 30, 2021, there were no shares of preferred stock issued or outstanding.

Warrants

– The warrants may only be exercised for a whole number of shares. The warrants included in the units being sold in the Proposed Public Offering (the “Public Warrants”) will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.

The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $18.00

: Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption; and

Table of Contents

•

if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).

The Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the

30-day

redemption period.

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Note 7 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than the Initial Public Offering, as described in these condensed financial statements, the Company did not identify any subsequent events, that require adjustment or disclosure in the condensed financial statements.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Alpha Healthcare Acquisition Corp. III. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to AHAC Sponsor III LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in

this Form 10-Q including,

without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the SEC on July 27, 2021. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated on January 21, 2021 as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our Initial Public Offering and the private placement of the Private Placement Units, our shares, debt or a combination of cash, equity and debt.

As indicated in the accompanying financial statements, as of June 30, 2021, we had no cash and deferred offering costs of approximately $315,178. Further, we expect to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful.

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for our Initial Public Offering. Following our Initial Public Offering, we will not generate any operating revenues until after completion of our initial business combination. We will generate

non-operating

income in the form of interest income on cash and cash equivalents after our Initial Public Offering. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After our Initial Public Offering, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. We expect our expenses to increase substantially after the closing of our Initial Public Offering.

Table of Contents

For the period from January 21, 2021 (inception) through June 30, 2021, we had a net loss of $7,576, which consisted of formation and operating costs.

Liquidity and Capital Resources

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B common stock by the Sponsor and loans from our Sponsor.

Subsequent to the end of the quarterly period covered by this Quarterly Report, on July 29, 2021, we consummated the Initial Public Offering of 15,000,000 Units at a price of $10.00 per Unit, generating gross proceeds of $150,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 455,000 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit generating gross proceeds of $4,550,000. We incurred $8,603,143 in transaction costs, including $3,000,000 of underwriting fees, $5,250,000 of deferred underwriting fees and $353,143 of other offering costs.

Following the Initial Public Offering, the sale of the Private Placement Units and the exercise of the over-allotment option, a total of $154,441,030 was placed in the Trust Account, and we had $1,550,000 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into placement units of the post-business combination entity at a price of $10.00 per placement unit at the option of the lender. The placement units would be identical to the units.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business,

undertaking in-depth due

diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Table of Contents

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities that would be considered

off-balance

sheet arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating

off-balance

sheet arrangements. We have not entered into any

off-balance

sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any

non-financial

assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for office space, secretarial and administrative services provided to the Company. We began incurring these fees on July 26, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.

The underwriters are entitled to a deferred fee of $0.35 per unit, or $5,250,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

JOBS Act

The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for

non-emerging

growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of

non-emerging

growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As of June 30, 2021, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in certain U.S. government securities with a maturity of 185 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

Item 4. Controls and Procedures.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

As required

by Rules 13a-15 and 15d-15 under

the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined

in Rules 13a-15 (e) and 15d-15 (e) under

the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our final prospectus for our Initial Public Offering filed with the SEC on July 27, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not currently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus for our Initial Public Offering filed with the SEC on July 27, 2021. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

On July 29, 2021, we consummated our Initial Public Offering of 15,000,000 Units at a price of $10.00 per Unit, generating total gross proceeds of $150,000,000. BofA Securities Inc. and PJT Partners LP acted as book-running managers. The securities sold in the offering were registered under the Securities Act on a registration statement on Form

S-1

(No.

333-253876).

The registration statements became effective on July 26, 2021.

Simultaneously with the consummation of the Initial Public Offering, we consummated a private placement of 455,000 Private Placement Units to our Sponsor at a price of $10.00 per Private Placement Unit, generating total proceeds of $4,550,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030. Resulting from the partial over-allotment exercise, the Company issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds.

A total of $154,441,030, composed of the proceeds of the Initial Public Offering, including from the exercise of the over-allotment option by the Underwriters, and the sale of the Private Placement Units, including $5,250,000 of the underwriters’ deferred discount, was placed in the Trust Account.

We paid a total of $3,000,000 in underwriting discounts and commissions and $353,143 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $5,250,000 in underwriting discounts and commissions.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form

10-Q.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Table of Contents

Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form

10-Q.


Exhibit Number		Description

1.1		Underwriting Agreement, dated July 26, 2021, by and among the Company, PJT Partners LP and BofA Securities, Inc., as representatives of the underwriters.(1)

3.1		Second Amended and Restated Certificate of Incorporation of the Company.(1)

4.1		Warrant Agreement, dated July 26, 2021, between the Company and Continental Stock Transfer & Trust Company.(1)

10.1		Investment Management Trust Agreement, dated July 26, 2021, between the Company and Continental Stock Transfer & Trust Company.(1)

10.2		Registration Rights Agreement, dated July 26, 2021, by and among the Company, the Sponsor and the other Holders (as defined therein) signatory thereto.(1)

10.3		Form of Indemnity Agreement (2)

10.4		Letter Agreement, dated July 26, 2021, by and among the Company, the Sponsor and each director and executive officer of the Company. (1)

10.5		Private Unit Purchase Agreement, dated July 26, 2021, between the Company and the Sponsor.(1)

31.1*		Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Table of Contents


101.INS *		XBRL Instance Document

101.SCH *		XBRL Taxonomy Extension Schema Document

101.CAL *		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*	Filed herewith.

Furnished

(1)	Previously filed as an exhibit to our Current Report on Form 8-K filed on July 29, 2021 and incorporated by reference herein.

(2)	Previously filed as Exhibit 10.3 to our Registration Statement on Form S-1 (File No. 333-253876) filed on March 4, 2021 and incorporated by reference herein.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 13th day of September, 2021.


ALPHA HEALTHCARE ACQUISITION CORP. III

By:		/s/ Rajiv Shukla
		Name: Rajiv Shukla
		Title: Chief Executive Officer

ALPHA HEALTHCARE ACQUISITION CORP. III

By:		/s/ Patrick A. Sturgeon
		Name: Patrick A. Sturgeon
		Title: Chief Financial Officer

EX-31.1 2 d211732dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rajiv Shukla, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 of Alpha Healthcare Acquisition Corp. III;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-31.2 3 d211732dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrick A. Sturgeon, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 of Alpha Healthcare Acquisition Corp. III;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-32.1 4 d211732dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Alpha Healthcare Acquisition Corp. III (the “Company”) on Form 10-Q for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rajiv Shukla, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-32.2 5 d211732dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Alpha Healthcare Acquisition Corp. III (the “Company”) on Form 10-Q for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Patrick A. Sturgeon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-101.SCH 6 alpau-20210630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheet link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheet (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements of Operations (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statements of Changes in Stockholder's Equity link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statements of Changes in Stockholder's Equity (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Stockholder's Equity link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Initial Public Offering - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Commitments & Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Stockholder's Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 alpau-20210630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 alpau-20210630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 alpau-20210630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Common Class B [Member] Document Information [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Document Quarterly Report Document Transition Report Entity Registrant Name Entity Central Index Key Entity File Number Entity Interactive Data Current Entity Current Reporting Status Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Entity Address, State or Province Current Fiscal Year End Date Entity Tax Identification Number Equity Components [Axis] Equity Component [Domain] Capital Units [Member] Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant [Member] Warrant [Member] Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 [Member] Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Assets [Abstract] Assets Deferred Offering Costs Current And Noncurrent. Deferred offering costs Deferred offering costs current and noncurrent. Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accrued Liabilities, Current Accrued offering costs and expenses Due to Related Parties, Current Due to related party Liabilities, Current Total current liabilities Commitments and Contingencies Commitments and Contingencies (Note 5) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding Common Stock, Value, Issued Common stock value Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholders' equity Beginning Balance Ending Balance Liabilities and Equity Total Liabilities and Stockholder's Equity Preferred Stock, Par or Stated Value Per Share Preferred stock par or stated value per share Preferred Stock, Shares Authorized Preferred stock shares authorized Preferred Stock, Shares Issued Preferred stock shares issued Preferred Stock, Shares Outstanding Preferred stock shares outstanding Common Stock, Par or Stated Value Per Share Common stock par or stated value per share Common Stock, Shares Authorized Common stock shares authorized Common Stock, Shares, Issued Common stock shares issued Common Stock, Shares, Outstanding Common stock shares outstanding Common Stock Shares Subject To Forfeiture Common Stock Shares Subject To Forfeiture Common stock shares subject to forfeiture. Stockholders' Equity Note, Stock Split Stockholders' Equity Note, Stock Split Sale of Stock [Axis] Sale of Stock [Domain] Over-Allotment Option [Member] Income Statement [Abstract] Operating Costs and Expenses Formation cost Other Expenses Other expenses Net Income (Loss) Attributable to Parent Net loss Net loss Weighted Average Number of Shares Outstanding, Basic and Diluted Basic and diluted weighted average shares outstanding Earnings Per Share, Basic and Diluted Basic and diluted net loss per share Statement of Stockholders' Equity [Abstract] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Shares, Outstanding Beginning Balance (in Shares) Ending Balance (in Shares) Stock Issued During Period, Value, Issued for Services Class B common stock issued to Sponsor (in Shares) Stock Issued During Period, Value, Issued for Services Stock Issued During Period, Shares, Issued for Services Class B common stock issued to Sponsor Stock Issued During Period, Shares, Issued for Services Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Changes in current assets and current liabilities: Increase (Decrease) in Accrued Liabilities Accrued offerings costs and expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Cash and Cash Equivalents, at Carrying Value Cash - end of the period Cash - January 21, 2021 (inception) Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental Disclosure of cash flow information: Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock Deferred offering costs paid by Sponsor in exchange for issuance of common stock. Deferred Offering Costs Included In Accrued Offerings Costs And Expenses Deferred offering costs included in accrued offerings costs and expenses Deferred offering costs included in accrued offerings costs and expenses. Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Financing Activities: Proceeds from Related Party Debt Proceeds from related party Payments of Stock Issuance Costs Payments of offering costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net Change in Cash Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Organization and Business Operations Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies Stockholders' Equity Note [Abstract] Initial Public Offering Disclosure [Text Block] Initial Public Offering Initial public offering disclosure. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments & Contingencies Equity [Abstract] Stockholders' Equity Note Disclosure [Text Block] Stockholder's Equity Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Emerging Growth Company Status [Policy Text Block] Emerging Growth Company Status Disclosure of accounting policy for emerging growth company status. Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Fair Value Measurement, Policy [Policy Text Block] Fair Value of Financial Instruments Offering Costs [Policy Text Block] Offering Costs Disclosure of accounting policy for offering costs. Income Tax, Policy [Policy Text Block] Income Taxes Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Derivatives, Policy [Policy Text Block] Derivative Instruments New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards Organization Consolidation And Presentation Of Financial Statements [Table] Organization consolidation and presentation of financial statements. IPO [Member] Related Party [Axis] Related Party [Domain] Sponsor [Member] Sponsor. Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Private Placement Warrants [Member] Private placement warrants. Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization consolidation and presentation of financial statements. Stock Issued During Period, Shares, New Issues Stock shares issued during the period shares Shares Issued, Price Per Share Shares Issued, Price Per Share Proceeds from Issuance Initial Public Offering Proceeds from Issuance Initial Public Offering Over Allotment Option Vesting Period Overallotment option vesting period Over allotment option vesting period. Class Of Warrants And Rights Issued During The Period Class of warrants and rights issued during the period Class of warrants and rights issued during the period. Class Of Warrants And Rights Issued Price Per Warrant Class Of Warrants and Rights Issued, Price Per Warrant Class of warrants and rights issued price per warrant. Proceeds from Issuance of Private Placement Proceeds from Issuance of Private Placement Stock Issuance Costs Stock issuance costs Stock issuance costs. Payments for Underwriting Expense Payments for Underwriting Expense Other Offering Costs Other Offering Costs Other offering costs. Deferred Offering Costs Current And Noncurrent Deferred Offering Costs Current And Noncurrent Deferred offering costs current and noncurrent. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock Issued During Period, Value, Stock Options Exercised Stock Issued During Period, Value, Stock Options Exercised Restricted Investments Term Restricted Investments Term Restricted investments term. Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated Percentage of public shares to be redeemed in case business combination is not consummated Percentage of public shares to be redeemed in case business combination is not consummated. Lock In Period For Redemption Of Public Shares After Closing Of IPO Lock In Period For Redemption Of Public Shares After Closing Of IPO Lock in period for redemption of public shares after closing of IPO. Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Banking Regulation, Mortgage Banking, Net Worth, Minimum Minimum Net Worth Required for Compliance Accrued Underwriting Fees Accrued underwriting fees Accrued underwriting fees. Agreement [Axis] Agreement. Agreement [Domain] Agreement. Underwriting Agreement [Member] Underwriting agreement. Cash Equivalents, at Carrying Value Cash Equivalents, at Carrying Value Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Unrecognized Tax Benefits Unrecognized Tax Benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accrued for interest and penalties Cash, FDIC Insured Amount FDIC Insured Amount Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Founder Shares [Member] Founder shares. Common Stock, Shares Subscribed but Unissued Common Stock, Shares Subscribed but Unissued Common Stock Forfeiture Provisions Lapsed Common Stock forfeiture provisions lapsed Common Stock forfeiture provisions lapsed. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Overallotment Option Vesting Period Overallotment option vesting period Over allotment option vesting period. Share Price Share price Number Of Trading Days For Determining The Share Price Number of trading days for determining the share price Number of trading days for determining the share price. Number Of Consecutive Trading Days For Determining The Share Price Number of consecutive trading days for determining the share price Number of consecutive trading days for determining the share price. Waiting Period After Which The Share Trading Days Are Considered Waiting period after which the share trading days are considered Waiting period after which the share trading days are considered. Debt Instrument, Face Amount Debt Instrument, Face Amount Notes Payable, Related Parties, Current Note payable – related party Related Parties Offering Costs Related parties offering costs Related parties offering costs. Related Party Transaction, Expenses from Transactions with Related Party Expenses from Transactions with Related Party Debt Instrument, Convertible, Carrying Amount of Equity Component Debt Instrument, Convertible, Warrants issued Debt Instrument, Convertible, Conversion Price Warrants issued price per warrant Related Party Transaction [Axis] Related Party Transaction [Domain] Promissory Note [Member] Promissory note. Office Space Administrative And Support Services [Member] Office space, administrative and support services. Working Capital Loan [Member] Working capital loan. Cash Underwriting Discount Percent Cash underwriting discount percent Cash underwriting discount percent. Payment Of Underwriting Discount Payment of underwriting discount Payment of underwriting discount. EX-101.PRE 10 alpau-20210630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 d211732d10q_htm.xml IDEA: XBRL DOCUMENT 0001842939 2021-01-21 2021-06-30 0001842939 2021-06-30 0001842939 2021-04-01 2021-06-30 0001842939 2021-01-21 2021-03-31 0001842939 2021-01-20 0001842939 2021-03-31 0001842939 us-gaap:CapitalUnitsMember 2021-01-21 2021-06-30 0001842939 us-gaap:WarrantMember 2021-01-21 2021-06-30 0001842939 alpau:PrivatePlacementWarrantsMember alpau:SponsorMember 2021-01-21 2021-06-30 0001842939 us-gaap:IPOMember 2021-01-21 2021-06-30 0001842939 alpau:SponsorMember us-gaap:CommonClassAMember 2021-01-21 2021-06-30 0001842939 alpau:SponsorMember 2021-01-21 2021-06-30 0001842939 alpau:OfficeSpaceAdministrativeAndSupportServicesMember 2021-01-21 2021-06-30 0001842939 us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-01-21 2021-06-30 0001842939 srt:MinimumMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-01-21 2021-06-30 0001842939 srt:MaximumMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-01-21 2021-06-30 0001842939 alpau:RedemptionOfWarrantsEqualsOrExceedsUsDollarEighteenPointZeroZeroMember 2021-01-21 2021-06-30 0001842939 us-gaap:CommonClassAMember alpau:RedemptionOfWarrantsEqualsOrExceedsUsDollarEighteenPointZeroZeroMember 2021-01-21 2021-06-30 0001842939 us-gaap:CommonClassAMember 2021-06-30 0001842939 us-gaap:CommonClassBMember 2021-06-30 0001842939 us-gaap:CommonClassBMember us-gaap:OverAllotmentOptionMember 2021-06-30 0001842939 us-gaap:IPOMember 2021-06-30 0001842939 alpau:SponsorMember us-gaap:CommonClassAMember 2021-06-30 0001842939 alpau:PromissoryNoteMember alpau:SponsorMember 2021-06-30 0001842939 alpau:WorkingCapitalLoanMember 2021-06-30 0001842939 srt:MinimumMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-06-30 0001842939 srt:MaximumMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-06-30 0001842939 alpau:FounderMember us-gaap:CommonClassAMember 2021-06-30 0001842939 us-gaap:WarrantMember 2021-06-30 0001842939 alpau:RedemptionOfWarrantsBelowUsDollarNinePointTwoZeroMember 2021-06-30 0001842939 alpau:RedemptionOfWarrantsEqualsOrExceedsUsDollarEighteenPointZeroZeroMember 2021-06-30 0001842939 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001842939 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-21 2021-03-31 0001842939 us-gaap:AdditionalPaidInCapitalMember 2021-01-21 2021-03-31 0001842939 us-gaap:RetainedEarningsMember 2021-01-21 2021-03-31 0001842939 alpau:PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-08-03 2021-08-03 0001842939 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-08-03 2021-08-03 0001842939 alpau:FounderSharesMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-08-03 2021-08-03 0001842939 us-gaap:OverAllotmentOptionMember 2021-08-03 2021-08-03 0001842939 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-29 0001842939 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-29 0001842939 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-29 2021-07-29 0001842939 srt:MaximumMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2021-07-29 2021-07-29 0001842939 us-gaap:SubsequentEventMember us-gaap:IPOMember 2021-07-29 2021-07-29 0001842939 alpau:FounderSharesMember 2021-01-21 0001842939 alpau:FounderSharesMember 2021-01-21 2021-01-21 0001842939 alpau:FounderSharesMember 2021-01-25 0001842939 alpau:PromissoryNoteMember alpau:SponsorMember 2021-01-25 0001842939 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-01-25 0001842939 alpau:FounderSharesMember 2021-01-25 2021-01-25 0001842939 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-01-25 2021-01-25 0001842939 us-gaap:CommonClassBMember 2021-03-01 0001842939 us-gaap:CommonClassAMember 2021-03-01 0001842939 us-gaap:PreferredStockMember 2021-03-01 0001842939 us-gaap:CommonClassBMember 2021-03-01 2021-03-01 0001842939 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember alpau:UnderwritingAgreementMember 2021-07-26 2021-07-26 0001842939 us-gaap:CommonClassAMember 2021-09-13 0001842939 us-gaap:CommonClassBMember 2021-09-13 0001842939 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001842939 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001842939 us-gaap:RetainedEarningsMember 2021-06-30 0001842939 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-20 0001842939 us-gaap:AdditionalPaidInCapitalMember 2021-01-20 0001842939 us-gaap:RetainedEarningsMember 2021-01-20 0001842939 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001842939 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001842939 us-gaap:RetainedEarningsMember 2021-03-31 shares iso4217:USD utr:Day utr:Month pure utr:Year iso4217:USD shares false Q2 0001842939 001-40228 --12-31 10-Q true 2021-06-30 2021 false Alpha Healthcare Acquisition Corp. III DE 86-1645738 1177 Avenue of the Americas 5th Floor New York NY 10036 646 494-3296 Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant ALPAU NASDAQ Class A Common Stock, par value $0.0001 per share ALPA NASDAQ Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 ALPAW NASDAQ Yes Yes Non-accelerated Filer true true false true 15000000 4312500 -315178

315178

240934

56820

297754

0.0001

1000000

0.0001

100000000

0.0001

10000000

4312500

431

24569

-7576

17424

315178

562500

1:1.2

4312500

1211

6365

-6365

-7576

3750000

0.00

562500

1:1.2

4312500

431

24569

25000

-1211

4312500

431

24569

-1211

23789

-6365

4312500

431

24569

-7576

17424

562500

1:1.2

4312500

-7576

1211

-6365

56820

50455

6365

25000 239723

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Organization and Business Operations </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Alpha Healthcare Acquisition Corp. III is a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target. While the Company may pursue an initial Business Combination target in any business or industry, it intends to focus its search on companies in the healthcare industry. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has selected December 31 as its fiscal year end. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021, the Company had not yet commenced any operations. All activity from January 21, 2021 (inception) through June 30, 2021, relates to the Company’s formation and the Public Offering (as defined below). </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The registration statement for the Company’s Public Offering was declared effective on July 26, 2021. On July 29, 2021 (“IPO Date”), the Company consummated the Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $150,000,000, which is described in Note 3. In connection with the IPO, the Company also granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option to purchase an additional 2,250,000 Public Units at the initial public offering price. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 455,000 Units (each, a “Private Placement Unit” and, collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to AHAC Sponsor III LLC (the “Sponsor”), generating gross proceeds of $4,550,000, which is described in Note 4. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the IPO Date, transaction costs amounted to $3,353,143, consisting of $3,000,000 of underwriting fees and $353,143 of other offering costs. The Company has also accrued underwriting fees of $5,250,000 that will be paid only if a business combination is entered into. In addition, cash of $1,550,000 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030. Resulting from the partial over-allotment exercise, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Following the closing of the Initial Public Offering on July 29, 2021, an amount of $154,441,030 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, including the Units sold upon the exercise of the over-allotment option, and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. Except for the withdrawal of interest income to pay the income taxes, the Company’s amended and restated certificate of incorporation and subject to the requirements of law and regulation, provides that none of the funds held in the Trust Account will be released from the Trust Account until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of the public shares if the Company is unable to consummate an initial Business Combination within 24 months from the closing of the Public Offering (the “Combination Period”), subject to applicable law, and (c) the redemption of the Company’s public shares properly submitted in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-initial</div> Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the interest earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete an initial Business Combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest (net of taxes payable), divided by the number of then outstanding public shares. The amount in the Trust Account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Sponsor has agreed (i) to waive its redemption rights with respect to any Founder Shares, private placement shares and public shares held by it in connection with the completion of the initial Business Combination, (ii) to waive its rights to liquidating distributions from the Trust Account with respect to any Founder Shares or private placement shares held by it if the Company fails to complete its Business Combination within the Combination Period, although the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any public shares it holds if the Company fails to complete its Business Combination within such time period, (iii) not to propose any amendment to the Company’s amended and restated certificate of incorporation that would modify the substance or timing of its obligation to redeem 100% of the public shares if the Company does not complete its initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-initial</div> Business Combination activity, unless the Company provides its public stockholders with the opportunity to redeem their shares, and (iv) to vote any Founder Shares held by it and any public shares purchased during or after the Public Offering in favor of the Company’s initial Business Combination. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per share due to reductions in the value of the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Going Concern Consideration </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period or time, which is considered to be one year from the issuance date of the condensed financial statements. On July 29, 2021, the Company consummated its Initial Public Offering at which time capital in excess of the funds deposited in the trust and/or used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date these financials are issued and therefore substantial doubt has been alleviated. </div></div>

15000000

10.00

150000000

P45D

2250000

455000 10.00

4550000

3353143

3000000

353143 5250000 1550000

444103

4441030

8882

88820

154441030

10.00

P185D P24M 1

0.50

10.00

5000001

10.00

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Significant Accounting Policies </div></div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 27, 2021, as well as the Company’s Current Reports on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K,</div> as filed with the SEC on July 29, 2021 and August 4, 2021. The interim results for the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company Status </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Offering costs amounted to $315,178 at June 30, 2021, which were charged to stockholders’ equity upon the completion of the Initial Public Offering. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The provision for income taxes was deemed to be de minimis for the period from January 21, 2021 (inception) through June 30, 2021. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Instruments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company issues warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">At the IPO Date, the Public Warrants (see Note 3) and Private Warrants (see Note 4) were accounted for as equity as these instruments meet all of the requirements for equity classification under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> </div><div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recently Issued Accounting Standards </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-06,</div> Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40)</div> (“ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06”),</div> which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and certain criteria under ASC 840 that is used to determine whether a derivative financial instrument meets the additional criteria necessary for equity classification. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this change will have on its financial statements. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company’s financial statements. </div></div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 27, 2021, as well as the Company’s Current Reports on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K,</div> as filed with the SEC on July 29, 2021 and August 4, 2021. The interim results for the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. </div>

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company Status </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div>

315178

250000

15000000

10.00

150000000.0

11.50

444103

4441030

8882

88820

3593750

0.0001

25000

0.00696

3593750

1:1.2

4312500

444103

2250000

111026

451464

P45D

12.00

P20D P30D P150D 455000

4550000

8882

88820

300000

56820

50455

10000

1500000

1.50

2250000

444103

4441030

0.020 3000000 3450000 0.035

5250000

6037500

<div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6 — Stockholder’s Equity </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock</div></div></div></div> — On January 25, 2021, the Company issued 3,593,750 shares of common stock, including an aggregate of up to 468,750 shares of common stock that were subject to forfeiture, to the Company by the initial stockholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial stockholders will collectively own 20% of the Company’s issued and outstanding common stock after the Proposed Public Offering. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 1, 2021, the Company amended its charter to authorize issuance of 100,000,000 Class A common stock, with a par value of $0.0001 per share, 10,000,000 Class B common stock, with a par value of $0.0001 per share, and 1,000,000 preferred stock, with a par value of $0.0001 per share, and effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding All shares and per share amounts have been retroactively restated to reflect the stock split. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">At June 30, 2021, there were (i) no shares of Class A common stock issued and outstanding and (ii) 4,312,500 shares of Class B common stock issued and outstanding, of which an aggregate of up to 562,500 shares of Class B common stock were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units out of the total 2,250,000 available under the over-allotments and the forfeiture term lapsed for 111,026 Founder Shares. The remaining 451,464 Founder Shares were forfeited upon the expiration of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> period reserved for the exercise of over-allotment option. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Both Class A and B stockholders will vote together as a single class on all matters submitted to a vote of the Company stockholders, with each share of common stock entitling the holder to one vote. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless our Sponsor agrees to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the sum of the total number of all shares of common stock </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">outstanding upon completion of the Proposed Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the Business Combination (after giving effect to any redemptions of shares of Class A common stock by public stockholders) (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination and any Private Placement Units issued to our Sponsor, officers or directors upon conversion of Working Capital Loans). The Sponsor may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preferred Stock</div></div></div></div> – The Company is authorized to issue 1,000,000 shares of preferred stock, with a par value of $0.0001 per share. At June 30, 2021, there were no shares of preferred stock issued or outstanding. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants</div></div></div></div> – The warrants may only be exercised for a whole number of shares. The warrants included in the units being sold in the Proposed Public Offering (the “Public Warrants”) will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the Newly Issued Price, (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, respectively. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per share of Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A common stock equals or exceeds $18.00</div></div>: Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of 30 days’ prior written notice of redemption; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: "Times New Roman"; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”). </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div>

3593750

468750

0.20

100000000

0.0001

10000000

0.0001

1000000

0.0001

1:1.2

4312500

562500 444103 2250000 111026 451464 0.20

1000000

0.0001

11.50

P5Y

9.20 0.60

9.20

1.15

18.00

1.80

18.00

0.01 P30D

18.00

P20D P30D P30D

This share quantity includes up to 562,500 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On March 1, 2021, the Company effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split. This share quantity excludes up to 562,500 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On March 1, 2021, the Company effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split.

XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover Page - shares	5 Months Ended
Cover Page - shares	Jun. 30, 2021	Sep. 13, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	Alpha Healthcare Acquisition Corp. III
Entity Central Index Key	0001842939
Entity File Number	001-40228
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1177 Avenue of the Americas
Entity Address, Address Line Two	5th Floor
Entity Address, City or Town	New York
Entity Address, Postal Zip Code	10036
City Area Code	646
Local Phone Number	494-3296
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ALPA
Security Exchange Name	NASDAQ
Entity Address, State or Province	NY
Current Fiscal Year End Date	--12-31
Entity Tax Identification Number	86-1645738
Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant
Trading Symbol	ALPAU
Security Exchange Name	NASDAQ
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Trading Symbol	ALPAW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		15,000,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		4,312,500

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheet

Jun. 30, 2021

USD ($)

Assets

Deferred offering costs

$ 315,178

Total assets

315,178

Current liabilities:

Accrued offering costs and expenses

240,934

Due to related party

56,820

Total current liabilities

297,754

Commitments and Contingencies (Note 5)

Stockholders' equity:

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

Additional paid-in capital

24,569

Accumulated deficit

(7,576)

Total stockholders' equity

17,424

Total Liabilities and Stockholder's Equity

315,178

Common Class A [Member]

Stockholders' equity:

Common stock value

Common Class B [Member]

Stockholders' equity:

Common stock value

$ 431

^[1]

[1]

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheet (Parenthetical) - $ / shares	Mar. 01, 2021	Jun. 30, 2021
Preferred stock par or stated value per share		$ 0.0001
Preferred stock shares authorized		1,000,000
Preferred stock shares issued		0
Preferred stock shares outstanding		0
Common Class A [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	100,000,000	100,000,000
Common stock shares issued		0
Common stock shares outstanding		0
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	10,000,000	10,000,000
Common stock shares issued		4,312,500
Common stock shares outstanding	4,312,500	4,312,500
Stockholders' Equity Note, Stock Split	1:1.2
Common Class B [Member] \| Over-Allotment Option [Member]
Common Stock Shares Subject To Forfeiture		562,500

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations - USD ($)

3 Months Ended

5 Months Ended

Jun. 30, 2021

Formation cost

$ 0

$ 1,211

Other expenses

6,365

Net loss

$ (6,365)

$ (7,576)

Basic and diluted weighted average shares outstanding

^[1]

3,750,000

Basic and diluted net loss per share

$ 0.00

[1]

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations (Parenthetical) - Common Class B [Member] - shares	Mar. 01, 2021	Jun. 30, 2021
Stockholders' Equity Note, Stock Split	1:1.2
Common stock shares outstanding	4,312,500	4,312,500
Over-Allotment Option [Member]
Common Stock Shares Subject To Forfeiture		562,500

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Stockholder's Equity - USD ($)

Total

Common Stock [Member]

Common Class B [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Beginning Balance at Jan. 20, 2021

$ 0

Beginning Balance (in Shares) at Jan. 20, 2021

^[1]

Class B common stock issued to Sponsor

25,000

431

24,569

Class B common stock issued to Sponsor (in Shares)

^[1]

$ 4,312,500

Net loss

$ (1,211)

(1,211)

Ending Balance at Mar. 31, 2021

23,789

$ 431

$ 24,569

(1,211)

Ending Balance (in Shares) at Mar. 31, 2021

^[1]

4,312,500

Beginning Balance at Jan. 20, 2021

$ 0

Beginning Balance (in Shares) at Jan. 20, 2021

^[1]

Net loss

(7,576)

Ending Balance at Jun. 30, 2021

17,424

$ 431

24,569

(7,576)

Ending Balance (in Shares) at Jun. 30, 2021

^[1]

4,312,500

Beginning Balance at Mar. 31, 2021

23,789

$ 431

24,569

(1,211)

Beginning Balance (in Shares) at Mar. 31, 2021

^[1]

4,312,500

Net loss

(6,365)

Ending Balance at Jun. 30, 2021

$ 17,424

$ 431

$ 24,569

$ (7,576)

Ending Balance (in Shares) at Jun. 30, 2021

^[1]

4,312,500

[1]

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 18 R7.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Stockholder's Equity (Parenthetical) - Common Class B [Member] - shares	Mar. 01, 2021	Jun. 30, 2021
Stockholders' Equity Note, Stock Split	1:1.2
Common stock shares outstanding	4,312,500	4,312,500
Over-Allotment Option [Member]
Common Stock Shares Subject To Forfeiture		562,500

XML 19 R8.htm IDEA: XBRL DOCUMENT

Condensed Statement of Cash Flows	5 Months Ended
Condensed Statement of Cash Flows	Jun. 30, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (7,576)
Changes in current assets and current liabilities:
Accrued offerings costs and expenses	1,211
Net cash used in operating activities	(6,365)
Cash Flows from Financing Activities:
Proceeds from related party	56,820
Payments of offering costs	(50,455)
Net cash provided by financing activities	6,365
Net Change in Cash	0
Cash - January 21, 2021 (inception)	0
Cash - end of the period	0
Supplemental Disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock	25,000
Deferred offering costs included in accrued offerings costs and expenses	$ 239,723

XML 20 R9.htm IDEA: XBRL DOCUMENT

Organization and Business Operations	5 Months Ended
Organization and Business Operations	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Alpha Healthcare Acquisition Corp. III is a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any Business Combination target. While the Company may pursue an initial Business Combination target in any business or industry, it intends to focus its search on companies in the healthcare industry. The Company has selected December 31 as its fiscal year end. As of June 30, 2021, the Company had not yet commenced any operations. All activity from January 21, 2021 (inception) through June 30, 2021, relates to the Company’s formation and the Public Offering (as defined below). The registration statement for the Company’s Public Offering was declared effective on July 26, 2021. On July 29, 2021 (“IPO Date”), the Company consummated the Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $150,000,000, which is described in Note 3. In connection with the IPO, the Company also granted the underwriters a 45-day option to purchase an additional 2,250,000 Public Units at the initial public offering price. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 455,000 Units (each, a “Private Placement Unit” and, collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to AHAC Sponsor III LLC (the “Sponsor”), generating gross proceeds of $4,550,000, which is described in Note 4. At the IPO Date, transaction costs amounted to $3,353,143, consisting of $3,000,000 of underwriting fees and $353,143 of other offering costs. The Company has also accrued underwriting fees of $5,250,000 that will be paid only if a business combination is entered into. In addition, cash of $1,550,000 was held outside of the Trust Account (as defined below) and is available for the payment of offering costs and for working capital purposes. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030. Resulting from the partial over-allotment exercise, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds. Following the closing of the Initial Public Offering on July 29, 2021, an amount of $154,441,030 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, including the Units sold upon the exercise of the over-allotment option, and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”), invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company. Except for the withdrawal of interest income to pay the income taxes, the Company’s amended and restated certificate of incorporation and subject to the requirements of law and regulation, provides that none of the funds held in the Trust Account will be released from the Trust Account until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of the public shares if the Company is unable to consummate an initial Business Combination within 24 months from the closing of the Public Offering (the “Combination Period”), subject to applicable law, and (c) the redemption of the Company’s public shares properly submitted in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination. The Company’s Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the interest earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete an initial Business Combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest (net of taxes payable), divided by the number of then outstanding public shares. The amount in the Trust Account is initially anticipated to be $10.00 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The shares of common stock subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, liquidate and dissolve, subject in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period. The Sponsor has agreed (i) to waive its redemption rights with respect to any Founder Shares, private placement shares and public shares held by it in connection with the completion of the initial Business Combination, (ii) to waive its rights to liquidating distributions from the Trust Account with respect to any Founder Shares or private placement shares held by it if the Company fails to complete its Business Combination within the Combination Period, although the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any public shares it holds if the Company fails to complete its Business Combination within such time period, (iii) not to propose any amendment to the Company’s amended and restated certificate of incorporation that would modify the substance or timing of its obligation to redeem 100% of the public shares if the Company does not complete its initial Business Combination within the Combination Period or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides its public stockholders with the opportunity to redeem their shares, and (iv) to vote any Founder Shares held by it and any public shares purchased during or after the Public Offering in favor of the Company’s initial Business Combination. The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per share due to reductions in the value of the trust assets, in each case less taxes payable, provided that such liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure you that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Going Concern Consideration Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period or time, which is considered to be one year from the issuance date of the condensed financial statements. On July 29, 2021, the Company consummated its Initial Public Offering at which time capital in excess of the funds deposited in the trust and/or used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date these financials are issued and therefore substantial doubt has been alleviated.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies	5 Months Ended
Significant Accounting Policies	Jun. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 27, 2021, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on July 29, 2021 and August 4, 2021. The interim results for the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Offering costs amounted to $315,178 at June 30, 2021, which were charged to stockholders’ equity upon the completion of the Initial Public Offering. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from January 21, 2021 (inception) through June 30, 2021. Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Derivative Instruments The Company issues warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815-40, including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification. At the IPO Date, the Public Warrants (see Note 3) and Private Warrants (see Note 4) were accounted for as equity as these instruments meet all of the requirements for equity classification under ASC 815-40. Recently Issued Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and certain criteria under ASC 840 that is used to determine whether a derivative financial instrument meets the additional criteria necessary for equity classification. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this change will have on its financial statements. Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company’s financial statements.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Initial Public Offering	5 Months Ended
Initial Public Offering	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering On July 29, 2021, the Company sold 15,000,000 Units at $10.00 per Unit, generating gross proceeds of $150.0 million. Each unit consists of one share of Class A common stock and one-fourth of one redeemable warrant. Only whole warrants are exercisable. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030, received on August 6, 2021. Resulting from the partial over-allotment exercise, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions	5 Months Ended
Related Party Transactions	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 — Related Party Transactions Founder Shares On January 21, 2021, the Sponsor subscribed to purchase 3,593,750 shares of the Company’s common stock, par value $0.0001 per share (the “Founder Shares”) for an aggregate price of $25,000. On January 25, 2021, the Sponsor paid $25,000, or approximately $0.00696 per share, to cover for certain offering and formation costs in consideration for 3,593,750 Founder Shares. On March 1, 2021, the Company effected a 1:1.2 stock split of its common stock which resulted in an aggregate of 4,312,500 shares of Class B common stock outstanding. All shares and associated amounts have been retroactively restated to reflect the stock split. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units out of the total 2,250,000 available under the over-allotments and the forfeiture provisions lapsed for 111,026 Founder Shares. The remaining 451,464 Founder Shares were forfeited upon the expiration of the 45-day period reserved for the exercise of over-allotment option. The Sponsor, directors and executive officers have agreed not to transfer, assign or sell (i) any of their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Company’s shares of Class A common stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of its public stockholders having the right to exchange their common stock for cash, securities or other property, and (ii) any of their Private Placement Units, placement shares, Private Placement Warrants and Class A common stock issued upon conversion or exercise thereof until 30 days after the completion of the initial Business Combination (the “Lock-up”). Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and directors and executive officers with respect to any Founder Shares, Private Placement Units, placement shares, Private Placement Warrants and Class A common stock issued upon conversion or exercise thereof. Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 455,000 Private Placement Units for an aggregate purchase price of $4,550,000, in a private placement. Each Private Placement Unit is identical to the Units sold in the Initial Public Offering except as described below. A portion of the proceeds from the Private Placement Units was added to the proceeds from the Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). Resulting from the partial over-allotment exercise on August 3, 2021, the Company also issued 8,882 Private Placement Units, generating additional $88,820 in gross proceeds. The Private Placement Units (including the placement shares, the placement warrants and Class A common stock issuable upon exercise of such placement warrants) will not be transferable or salable until 30 days after the completion of our Business Combination (except, among other limited exceptions, to our officers and directors and other persons or entities affiliated with our Sponsor). Promissory Note — Related Party On January 25, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 to be used for a portion of the expenses of the Proposed Public Offering. This loan is non-interest bearing, unsecured, and due at the earlier of (i) the date on which the Company consummates the initial public offering and (ii) the date on which the Company determines not to conduct an initial public offering of its securities, upon request from the Company the Sponsor. The loan will be repaid upon the closing of the Proposed Public Offering out of the offering proceeds not held in the Trust Account. As of June 30, 2021, the Company had no borrowings outstanding under the promissory note. Due to Related Party The balance of $56,820 as of June 30, 2021, of which $50,455 represents the offering costs paid by the Sponsor on behalf of the Company. Administrative Service Fee The Company has agreed, commencing on the date that the Company’s securities are first listed on the Nasdaq, to pay an affiliate of the Sponsor a monthly fee of an aggregate of $10,000 for office space, administrative and support services. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.50 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2021, there were no written agreements in place for the Working Capital Loans..

XML 24 R13.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies	5 Months Ended
Commitments & Contingencies	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 5 — Commitments & Contingencies Registration Rights The holders of the Founder Shares, Private Placement Units, Private Placement Warrants, Class A common stock underlying the Private Placement Warrants and Private Placement Units that may be issued upon conversion of Working Capital Loans (and any shares or Class A common stock issuable upon the exercise of the Private Placement Warrants and Private Placement Units that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement dated July 26, 2021. The holders of these securities are entitled to make unlimited demands that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, as described in the following paragraph, and (ii) in the case of the Private Placement Warrants and the respective shares of Class A common stock underlying such warrants, 30 days after the completion of the Company’s initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriters Agreement The Company granted the underwriters a 45-day option from July 26, 2021, to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions. On August 3, 2021, the Underwriters exercised their option to purchase 444,103 additional Units for the total amount of $4,441,030. The underwriters received a cash underwriting discount of two percent (2.0%) of the gross proceeds of the Public Offering, or $3,000,000 (or up to $3,450,000 if the underwriters’ over-allotment is exercised in full), paid on July 29, 2021. In addition, the underwriters will be entitled to a deferred underwriting fee of three and a half percent (3.5%), or $5,250,000 of the gross proceeds of the Public Offering (or up to $6,037,500 if the underwriters’ over-allotment is exercised in full) upon the completion of the Company’s initial Business Combination. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Stockholder's Equity

5 Months Ended

Jun. 30, 2021

Equity [Abstract]

Stockholder's Equity

Note 6 — Stockholder’s Equity

Common Stock

45-day

period reserved for the exercise of over-allotment option.

Both Class A and B stockholders will vote together as a single class on all matters submitted to a vote of the Company stockholders, with each share of common stock entitling the holder to one vote.

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a

one-for-one

as-converted

basis, 20% of the sum of the total number of all shares of common stock

Preferred Stock

– The Company is authorized to issue 1,000,000 shares of preferred stock, with a par value of $0.0001 per share. At June 30, 2021, there were no shares of preferred stock issued or outstanding.

Warrants

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $18.00

: Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption; and

•

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).

30-day

redemption period.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 26 R15.htm IDEA: XBRL DOCUMENT

Subsequent Events	5 Months Ended
Subsequent Events	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 7 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than the Initial Public Offering, as described in these condensed financial statements, the Company did not identify any subsequent events, that require adjustment or disclosure in the condensed financial statements.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	5 Months Ended
Significant Accounting Policies (Policies)	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 27, 2021, as well as the Company’s Current Reports on Form 8-K, as filed with the SEC on July 29, 2021 and August 4, 2021. The interim results for the three months ended June 30, 2021 and for the period from January 21, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Offering Costs	Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Public Shares were charged to stockholders’ equity upon the completion of the Initial Public Offering. Offering costs amounted to $315,178 at June 30, 2021, which were charged to stockholders’ equity upon the completion of the Initial Public Offering.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from January 21, 2021 (inception) through June 30, 2021.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Instruments	Derivative Instruments The Company issues warrants to its investors and accounts for warrant instruments as either equity-classified or liability-classified instruments based on an assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification under ASC 815-40, including whether the warrants are indexed to the Company’s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification. At the IPO Date, the Public Warrants (see Note 3) and Private Warrants (see Note 4) were accounted for as equity as these instruments meet all of the requirements for equity classification under ASC 815-40.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments and certain criteria under ASC 840 that is used to determine whether a derivative financial instrument meets the additional criteria necessary for equity classification. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this change will have on its financial statements. Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not, or are not believed by management to, have a material impact on the Company’s financial statements.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Organization and Business Operations - Additional Information (Detail) - USD ($)				5 Months Ended
	Aug. 03, 2021	Jul. 29, 2021	Jul. 26, 2021	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Shares Issued, Price Per Share				$ 10.00
Restricted Investments Term				185 days
Lock In Period For Redemption Of Public Shares After Closing Of IPO				24 months
Percentage of public shares to be redeemed in case business combination is not consummated				100.00%
Equity Method Investment, Ownership Percentage				50.00%
Minimum Net Worth Required for Compliance				$ 5,000,001
Sponsor [Member] \| Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period				455,000
Class Of Warrants and Rights Issued, Price Per Warrant				$ 10.00
Proceeds from Issuance of Private Placement				$ 4,550,000
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issuance costs				3,353,143
Payments for Underwriting Expense				3,000,000
Other Offering Costs				353,143
Deferred Offering Costs Current And Noncurrent				1,550,000
Accrued underwriting fees				$ 5,250,000
Subsequent Event [Member] \| IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Shares Issued, Price Per Share		$ 10.00
Proceeds from Issuance Initial Public Offering		$ 154,441,030
Subsequent Event [Member] \| Over-Allotment Option [Member] \| Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants and rights issued during the period	8,882
Proceeds from Issuance of Private Placement	$ 88,820
Subsequent Event [Member] \| Common Class A [Member] \| IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock shares issued during the period shares		15,000,000
Shares Issued, Price Per Share		$ 10.00
Proceeds from Issuance Initial Public Offering		$ 150,000,000
Overallotment option vesting period		45 days
Subsequent Event [Member] \| Maximum [Member] \| Common Class A [Member] \| Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock shares issued during the period shares		2,250,000
Subsequent Event [Member] \| Underwriting Agreement [Member] \| Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock shares issued during the period shares			2,250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	444,103
Stock Issued During Period, Value, Stock Options Exercised	$ 4,441,030

XML 29 R18.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Additional Information (Detail)	5 Months Ended
	Jun. 30, 2021 USD ($)
Accounting Policies [Abstract]
Cash Equivalents, at Carrying Value	$ 0
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	315,178
Unrecognized Tax Benefits	0
Accrued for interest and penalties	0
FDIC Insured Amount	$ 250,000

XML 30 R19.htm IDEA: XBRL DOCUMENT

Initial Public Offering - Additional information (Detail) - USD ($)	Aug. 03, 2021	Jul. 29, 2021	Jul. 26, 2021	Jun. 30, 2021
Shares Issued, Price Per Share				$ 10.00
Subsequent Event [Member] \| IPO [Member]
Shares Issued, Price Per Share		$ 10.00
Proceeds from Issuance Initial Public Offering		$ 154,441,030
Subsequent Event [Member] \| Over-Allotment Option [Member] \| Private Placement Warrants [Member]
Class of warrants and rights issued during the period	8,882
Proceeds from Issuance of Private Placement	$ 88,820
Subsequent Event [Member] \| Common Class A [Member] \| IPO [Member]
Stock shares issued during the period shares		15,000,000
Shares Issued, Price Per Share		$ 10.00
Proceeds from Issuance Initial Public Offering		$ 150,000,000
Exercise price of warrant		$ 11.50
Subsequent Event [Member] \| Underwriting Agreement [Member] \| Over-Allotment Option [Member]
Stock shares issued during the period shares			2,250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	444,103
Stock Issued During Period, Value, Stock Options Exercised	$ 4,441,030

XML 31 R20.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Detail) - USD ($)						2 Months Ended	5 Months Ended
	Aug. 03, 2021	Jul. 26, 2021	Mar. 01, 2021	Jan. 25, 2021	Jan. 21, 2021	Mar. 31, 2021	Jun. 30, 2021
Shares Issued, Price Per Share							$ 10.00
Stock Issued During Period, Shares, Issued for Services						25,000
Due to related party							$ 56,820
Office Space Administrative And Support Services [Member]
Expenses from Transactions with Related Party							10,000
Working Capital Loan [Member]
Due to related party							0
Debt Instrument, Convertible, Warrants issued							$ 1,500,000
Warrants issued price per warrant							$ 1.50
Sponsor [Member]
Related parties offering costs							$ 50,455
Sponsor [Member] \| Promissory Note [Member]
Debt Instrument, Face Amount				$ 300,000
Note payable – related party							$ 0
Sponsor [Member] \| Private Placement Warrants [Member]
Class of warrants and rights issued during the period							455,000
Proceeds from Issuance of Private Placement							$ 4,550,000
Subsequent Event [Member] \| Over-Allotment Option [Member] \| Private Placement Warrants [Member]
Class of warrants and rights issued during the period	8,882
Proceeds from Issuance of Private Placement	$ 88,820
Underwriting Agreement [Member] \| Subsequent Event [Member] \| Over-Allotment Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	444,103
Stock shares issued during the period shares		2,250,000
Common Class A [Member]
Common stock par or stated value per share			$ 0.0001				$ 0.0001
Common stock shares outstanding							0
Common Class A [Member] \| Sponsor [Member]
Share price							$ 12.00
Number of trading days for determining the share price							20 days
Number of consecutive trading days for determining the share price							30 days
Waiting period after which the share trading days are considered							150 days
Founder Shares [Member]
Common Stock, Shares Subscribed but Unissued					3,593,750
Common stock par or stated value per share					$ 0.0001
Stock Issued During Period, Value, Issued for Services				$ 25,000	$ 25,000
Shares Issued, Price Per Share				$ 0.00696
Stock Issued During Period, Shares, Issued for Services				3,593,750
Founder Shares [Member] \| Subsequent Event [Member] \| Over-Allotment Option [Member]
Stock shares issued during the period shares	2,250,000
Common Stock forfeiture provisions lapsed	111,026
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited	451,464
Overallotment option vesting period	45 days
Common Class B [Member]
Common stock par or stated value per share			$ 0.0001				$ 0.0001
Stockholders' Equity Note, Stock Split			1:1.2
Common stock shares outstanding			4,312,500				4,312,500

XML 32 R21.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies - Additional Information (Detail) - Over-Allotment Option [Member] - Underwriting Agreement [Member] - USD ($)			5 Months Ended
	Aug. 03, 2021	Jul. 26, 2021	Jun. 30, 2021
Cash underwriting discount percent			2.00%
Deferred underwriting fee percent			3.50%
Minimum [Member]
Payment of underwriting discount			$ 3,000,000
Deferred underwriting commission			5,250,000
Maximum [Member]
Payment of underwriting discount			3,450,000
Deferred underwriting commission			$ 6,037,500
Subsequent Event [Member]
Stock shares issued during the period shares		2,250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	444,103
Stock Issued During Period, Value, Stock Options Exercised	$ 4,441,030

XML 33 R22.htm IDEA: XBRL DOCUMENT

Stockholder's Equity - Additional Information (Detail) - $ / shares				5 Months Ended
	Aug. 03, 2021	Mar. 01, 2021	Jan. 25, 2021	Jun. 30, 2021
Class of Stock [Line Items]
Equity Method Investment, Ownership Percentage				50.00%
Preferred stock par or stated value per share				$ 0.0001
Preferred stock shares authorized				1,000,000
Preferred stock shares issued				0
Preferred stock shares outstanding				0
Volume weighted average price of shares				$ 9.20
Proceeds from equity used for funding business combination as a percentage of the total				60.00%
Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 11.50
Warrants and rights outstanding term				5 years
Common Class A [Member]
Class of Stock [Line Items]
Common stock par or stated value per share		$ 0.0001		$ 0.0001
Common stock shares authorized		100,000,000		100,000,000
Common stock shares issued				0
Common stock shares outstanding				0
Common Class A [Member] \| Founder [Member]
Class of Stock [Line Items]
Percentage of common stock issued and outstanding				20.00%
Common Class B [Member]
Class of Stock [Line Items]
Common stock par or stated value per share		$ 0.0001		$ 0.0001
Common stock shares authorized		10,000,000		10,000,000
Common stock shares issued				4,312,500
Common stock shares outstanding		4,312,500		4,312,500
Stockholders' Equity Note, Stock Split		1:1.2
Stock Issued During Period, Shares, Stock Splits		4,312,500
Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock par or stated value per share		$ 0.0001
Preferred stock shares authorized		1,000,000
Redemption of warrants equals or exceeds $18.00 [Member]
Class of Stock [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price				180.00%
Share price				$ 18.00
Class of warrants or rights redemption price per unit				$ 0.01
Notice period of redemption warrant				30 days
Securities for capital with closing of initial business combination				20 days
Third trading day prior to date on which company notice of redemption				30 days
Redemption of warrants equals or exceeds $18.00 [Member] \| Common Class A [Member]
Class of Stock [Line Items]
Notice period of redemption warrant				30 days
Redemption of warrants below $9.20 [Member]
Class of Stock [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price				115.00%
Share price				$ 9.20
Over-Allotment Option [Member]
Class of Stock [Line Items]
Number of additional shares purchased	444,103
Number of shares available for purchase	2,250,000
Number of shares lapsed	111,026
Number of founder shares forfeited	451,464
Over-Allotment Option [Member] \| Common Class B [Member]
Class of Stock [Line Items]
Common Stock Shares Subject To Forfeiture				562,500
Over-Allotment Option [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock shares issued during the period shares			3,593,750
Common Stock Shares Subject To Forfeiture			468,750
Equity Method Investment, Ownership Percentage			20.00%

EXCEL 34 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

G>F1[(*-IP'@VZJRN.N6UR3/SX QWYUSGC\3G/RH>(Y1Q3 MKM66H*6^PM'E 7L:ZJ3=W(G57J1%65W8(GG$VQO$8$_]^3@DP^'K0K_%[W3AHAI-Q/; MXL?KT$Q@9R&WY.M'2.>@_NZJI897Z?C[5FE#FK2;-2NKW9F65=D:M'V^/%1; M#5?2;Y-E':^[8^(5-*P6?%]6"QI6"[I9[;AX52"[-Y?A@-81J<"2%=_R0R=\,%JLRDP:L, MJ(C;RS'/R*(0@DAEE_:&0>8;!U#@_5FM%3=XYN1$ Q#7;T>G??)'1CXR%278 M;]RM^,P)X%'F+-L0P*M39!F5$7I%^\'6VAS9Q?K L9N_\F.=<,1"#W%"*4UB M^+-<*E@B,UN1X=F O@W%-M%?0>WTM#ZY1;^V?1 9#;?+B#NN9ZDL[*4B82L@ M

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end XML 35 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 36 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 67 210 1 true 24 0 false 7 false false R1.htm 1001 - Document - Cover Page Sheet http://www.constellationalpha.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheet Sheet http://www.constellationalpha.com/role/CondensedBalanceSheet Condensed Balance Sheet Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheet (Parenthetical) Sheet http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical Condensed Balance Sheet (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements of Operations Sheet http://www.constellationalpha.com/role/CondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements of Operations (Parenthetical) Sheet http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical Condensed Statements of Operations (Parenthetical) Statements 5 false false R6.htm 1006 - Statement - Condensed Statements of Changes in Stockholder's Equity Sheet http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity Condensed Statements of Changes in Stockholder's Equity Statements 6 false false R7.htm 1007 - Statement - Condensed Statements of Changes in Stockholder's Equity (Parenthetical) Sheet http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical Condensed Statements of Changes in Stockholder's Equity (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Condensed Statement of Cash Flows Sheet http://www.constellationalpha.com/role/CondensedStatementOfCashFlows Condensed Statement of Cash Flows Statements 8 false false R9.htm 1009 - Disclosure - Organization and Business Operations Sheet http://www.constellationalpha.com/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 9 false false R10.htm 1010 - Disclosure - Significant Accounting Policies Sheet http://www.constellationalpha.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 1011 - Disclosure - Initial Public Offering Sheet http://www.constellationalpha.com/role/InitialPublicOffering Initial Public Offering Notes 11 false false R12.htm 1012 - Disclosure - Related Party Transactions Sheet http://www.constellationalpha.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 1013 - Disclosure - Commitments & Contingencies Sheet http://www.constellationalpha.com/role/CommitmentsContingencies Commitments & Contingencies Notes 13 false false R14.htm 1014 - Disclosure - Stockholder's Equity Sheet http://www.constellationalpha.com/role/StockholderSEquity Stockholder's Equity Notes 14 false false R15.htm 1015 - Disclosure - Subsequent Events Sheet http://www.constellationalpha.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 1016 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.constellationalpha.com/role/SignificantAccountingPolicies 16 false false R17.htm 1017 - Disclosure - Organization and Business Operations - Additional Information (Detail) Sheet http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail Organization and Business Operations - Additional Information (Detail) Details 17 false false R18.htm 1018 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 18 false false R19.htm 1019 - Disclosure - Initial Public Offering - Additional information (Detail) Sheet http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional information (Detail) Details 19 false false R20.htm 1020 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 20 false false R21.htm 1021 - Disclosure - Commitments & Contingencies - Additional Information (Detail) Sheet http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail Commitments & Contingencies - Additional Information (Detail) Details 21 false false R22.htm 1022 - Disclosure - Stockholder's Equity - Additional Information (Detail) Sheet http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail Stockholder's Equity - Additional Information (Detail) Details 22 false false All Reports Book All Reports d211732d10q.htm alpau-20210630.xsd alpau-20210630_cal.xml alpau-20210630_def.xml alpau-20210630_lab.xml alpau-20210630_pre.xml d211732dex311.htm d211732dex312.htm d211732dex321.htm d211732dex322.htm http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 40 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d211732d10q.htm": { "axisCustom": 2, "axisStandard": 8, "contextCount": 67, "dts": { "calculationLink": { "local": [ "alpau-20210630_cal.xml" ] }, "definitionLink": { "local": [ "alpau-20210630_def.xml" ] }, "inline": { "local": [ "d211732d10q.htm" ] }, "labelLink": { "local": [ "alpau-20210630_lab.xml" ], "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml" ] }, "presentationLink": { "local": [ "alpau-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml" ] }, "schema": { "local": [ "alpau-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 218, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 5, "total": 5 }, "keyCustom": 38, "keyStandard": 172, "memberCustom": 10, "memberStandard": 13, "nsprefix": "alpau", "nsuri": "http://www.constellationalpha.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.constellationalpha.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Significant Accounting Policies", "role": "http://www.constellationalpha.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "alpau:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Initial Public Offering", "role": "http://www.constellationalpha.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "alpau:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Related Party Transactions", "role": "http://www.constellationalpha.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Commitments & Contingencies", "role": "http://www.constellationalpha.com/role/CommitmentsContingencies", "shortName": "Commitments & Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Stockholder's Equity", "role": "http://www.constellationalpha.com/role/StockholderSEquity", "shortName": "Stockholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Subsequent Events", "role": "http://www.constellationalpha.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Organization and Business Operations - Additional Information (Detail)", "role": "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "shortName": "Organization and Business Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "lang": "en-US", "name": "alpau:RestrictedInvestmentsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Initial Public Offering - Additional information (Detail)", "role": "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "alpau:InitialPublicOfferingDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn07_29_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "alpau:DeferredOfferingCostsCurrentAndNoncurrent.", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance Sheet", "role": "http://www.constellationalpha.com/role/CondensedBalanceSheet", "shortName": "Condensed Balance Sheet", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "alpau:DeferredOfferingCostsCurrentAndNoncurrent.", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021_OfficeSpaceAdministrativeAndSupportServicesMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis_UnderwritingAgreementMemberALPAUAgreementAxis", "decimals": "3", "first": true, "lang": null, "name": "alpau:CashUnderwritingDiscountPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Commitments & Contingencies - Additional Information (Detail)", "role": "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "shortName": "Commitments & Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis_UnderwritingAgreementMemberALPAUAgreementAxis", "decimals": "3", "first": true, "lang": null, "name": "alpau:CashUnderwritingDiscountPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Stockholder's Equity - Additional Information (Detail)", "role": "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail", "shortName": "Stockholder's Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "lang": null, "name": "alpau:VolumeWeightedAveragePriceOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance Sheet (Parenthetical)", "role": "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "shortName": "Condensed Balance Sheet (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statements of Operations", "role": "http://www.constellationalpha.com/role/CondensedStatementsOfOperations", "shortName": "Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P03_01_2021To03_01_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplit", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statements of Operations (Parenthetical)", "role": "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "shortName": "Condensed Statements of Operations (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "PAsOn01_20_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statements of Changes in Stockholder's Equity", "role": "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "shortName": "Condensed Statements of Changes in Stockholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To03_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P03_01_2021To03_01_2021_CommonClassBMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplit", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Condensed Statements of Changes in Stockholder's Equity (Parenthetical)", "role": "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "shortName": "Condensed Statements of Changes in Stockholder's Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Condensed Statement of Cash Flows", "role": "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows", "shortName": "Condensed Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Organization and Business Operations", "role": "http://www.constellationalpha.com/role/OrganizationAndBusinessOperations", "shortName": "Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d211732d10q.htm", "contextRef": "P01_21_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 24, "tag": { "alpau_AccruedUnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued underwriting fees.", "label": "Accrued Underwriting Fees", "terseLabel": "Accrued underwriting fees" } } }, "localname": "AccruedUnderwritingFees", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_AdjustedExercisePriceOfWarrantsAsAPercentageOfNewlyIssuedPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted exercise price of warrants as a percentage of newly issued price.", "label": "Adjusted Exercise Price Of Warrants As A Percentage Of Newly Issued Price", "verboseLabel": "Adjusted exercise price of warrants as a percentage of newly issued price" } } }, "localname": "AdjustedExercisePriceOfWarrantsAsAPercentageOfNewlyIssuedPrice", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_AdjustedExercisePriceOfWarrantsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted exercise price of warrants.", "label": "Adjusted Exercise Price Of Warrants [Axis]" } } }, "localname": "AdjustedExercisePriceOfWarrantsAxis", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "alpau_AdjustedExercisePriceOfWarrantsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted exercise price of warrants.", "label": "Adjusted Exercise Price Of Warrants [Domain]" } } }, "localname": "AdjustedExercisePriceOfWarrantsDomain", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "alpau_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_CashUnderwritingDiscountPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash underwriting discount percent.", "label": "Cash Underwriting Discount Percent", "verboseLabel": "Cash underwriting discount percent" } } }, "localname": "CashUnderwritingDiscountPercent", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_ClassOfWarrantsAndRightsIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued during the period.", "label": "Class Of Warrants And Rights Issued During The Period", "verboseLabel": "Class of warrants and rights issued during the period" } } }, "localname": "ClassOfWarrantsAndRightsIssuedDuringThePeriod", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_ClassOfWarrantsAndRightsIssuedPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued price per warrant.", "label": "Class Of Warrants And Rights Issued Price Per Warrant", "verboseLabel": "Class Of Warrants and Rights Issued, Price Per Warrant" } } }, "localname": "ClassOfWarrantsAndRightsIssuedPricePerWarrant", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "alpau_ClassOfWarrantsOrRightsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights redemption price per unit.", "label": "Class Of Warrants Or Rights Redemption Price Per Unit", "verboseLabel": "Class of warrants or rights redemption price per unit" } } }, "localname": "ClassOfWarrantsOrRightsRedemptionPricePerUnit", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "alpau_CommonStockForfeitureProvisionsLapsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock forfeiture provisions lapsed.", "label": "Common Stock Forfeiture Provisions Lapsed", "verboseLabel": "Common Stock forfeiture provisions lapsed" } } }, "localname": "CommonStockForfeitureProvisionsLapsed", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_CommonStockSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares subject to forfeiture.", "label": "Common Stock Shares Subject To Forfeiture", "verboseLabel": "Common Stock Shares Subject To Forfeiture" } } }, "localname": "CommonStockSharesSubjectToForfeiture", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_DeferredOfferingCostsCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs current and noncurrent.", "label": "Deferred Offering Costs Current And Noncurrent", "verboseLabel": "Deferred Offering Costs Current And Noncurrent" } } }, "localname": "DeferredOfferingCostsCurrentAndNoncurrent", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_DeferredOfferingCostsCurrentAndNoncurrent.": { "auth_ref": [], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs current and noncurrent.", "label": "Deferred Offering Costs Current And Noncurrent.", "negatedLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCostsCurrentAndNoncurrent.", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "alpau_DeferredOfferingCostsIncludedInAccruedOfferingsCostsAndExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in accrued offerings costs and expenses.", "label": "Deferred Offering Costs Included In Accrued Offerings Costs And Expenses", "verboseLabel": "Deferred offering costs included in accrued offerings costs and expenses" } } }, "localname": "DeferredOfferingCostsIncludedInAccruedOfferingsCostsAndExpenses", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "alpau_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs paid by Sponsor in exchange for issuance of common stock.", "label": "Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock", "verboseLabel": "Deferred offering costs paid by Sponsor in exchange for issuance of Class\u00a0B common stock" } } }, "localname": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "alpau_DeferredUnderwritingFeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fee percent.", "label": "Deferred Underwriting Fee Percent", "verboseLabel": "Deferred underwriting fee percent" } } }, "localname": "DeferredUnderwritingFeePercent", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_EmergingGrowthCompanyStatusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for emerging growth company status.", "label": "Emerging Growth Company Status [Policy Text Block]", "verboseLabel": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyStatusPolicyTextBlock", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "alpau_FounderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder.", "label": "Founder [Member]" } } }, "localname": "FounderMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares.", "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_InitialPublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering disclosure.", "label": "Initial Public Offering Disclosure [Text Block]", "verboseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingDisclosureTextBlock", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "alpau_LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock in period for redemption of public shares after closing of IPO.", "label": "Lock In Period For Redemption Of Public Shares After Closing Of IPO", "verboseLabel": "Lock In Period For Redemption Of Public Shares After Closing Of IPO" } } }, "localname": "LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_NoticePeriodOfRedemptionWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notice period of redemption warrant.", "label": "Notice Period Of Redemption Warrant", "terseLabel": "Notice period of redemption warrant" } } }, "localname": "NoticePeriodOfRedemptionWarrant", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_NumberOfAdditionalSharesPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares purchased.", "label": "Number Of Additional Shares Purchased", "verboseLabel": "Number of additional shares purchased" } } }, "localname": "NumberOfAdditionalSharesPurchased", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining the share price.", "label": "Number Of Consecutive Trading Days For Determining The Share Price", "verboseLabel": "Number of consecutive trading days for determining the share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_NumberOfFounderSharesForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of founder shares forfeited.", "label": "Number Of Founder Shares Forfeited", "verboseLabel": "Number of founder shares forfeited" } } }, "localname": "NumberOfFounderSharesForfeited", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_NumberOfSharesAvailableForPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares available for purchase.", "label": "Number Of Shares Available For Purchase", "verboseLabel": "Number of shares available for purchase" } } }, "localname": "NumberOfSharesAvailableForPurchase", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_NumberOfSharesLapsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares lapsed.", "label": "Number Of Shares Lapsed", "verboseLabel": "Number of shares lapsed" } } }, "localname": "NumberOfSharesLapsed", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "alpau_NumberOfTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining the share price.", "label": "Number Of Trading Days For Determining The Share Price", "verboseLabel": "Number of trading days for determining the share price" } } }, "localname": "NumberOfTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_OfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for offering costs.", "label": "Offering Costs [Policy Text Block]", "verboseLabel": "Offering Costs" } } }, "localname": "OfferingCostsPolicyTextBlock", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "alpau_OfficeSpaceAdministrativeAndSupportServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office space, administrative and support services.", "label": "Office Space Administrative And Support Services [Member]" } } }, "localname": "OfficeSpaceAdministrativeAndSupportServicesMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "alpau_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "alpau_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other Offering Costs", "verboseLabel": "Other Offering Costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_OverAllotmentOptionVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over allotment option vesting period.", "label": "Over Allotment Option Vesting Period", "verboseLabel": "Overallotment option vesting period" } } }, "localname": "OverAllotmentOptionVestingPeriod", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_OverallotmentOptionVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Over allotment option vesting period.", "label": "Overallotment Option Vesting Period", "verboseLabel": "Overallotment option vesting period" } } }, "localname": "OverallotmentOptionVestingPeriod", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_PaymentOfUnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of underwriting discount.", "label": "Payment Of Underwriting Discount", "verboseLabel": "Payment of underwriting discount" } } }, "localname": "PaymentOfUnderwritingDiscount", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock issued and outstanding.", "label": "Percentage Of Common Stock Issued And Outstanding", "verboseLabel": "Percentage of common stock issued and outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of public shares to be redeemed in case business combination is not consummated.", "label": "Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated", "verboseLabel": "Percentage of public shares to be redeemed in case business combination is not consummated" } } }, "localname": "PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from equity used for funding business combination as a percentage of the total.", "label": "Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total", "verboseLabel": "Proceeds from equity used for funding business combination as a percentage of the total" } } }, "localname": "ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "alpau_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note.", "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_RedemptionOfWarrantsBelowUsDollarNinePointTwoZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redemption Of Warrants Below US Dollar Nine Point Two Zero [Member]", "terseLabel": "Redemption of warrants below $9.20 [Member]" } } }, "localname": "RedemptionOfWarrantsBelowUsDollarNinePointTwoZeroMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_RedemptionOfWarrantsEqualsOrExceedsUsDollarEighteenPointZeroZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redemption Of Warrants Equals Or Exceeds US Dollar Eighteen Point Zero Zero [Member]", "terseLabel": "Redemption of warrants equals or exceeds $18.00 [Member]" } } }, "localname": "RedemptionOfWarrantsEqualsOrExceedsUsDollarEighteenPointZeroZeroMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_RedemptionWarrantsTriggerPriceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redemption Warrants Trigger Price [Axis]" } } }, "localname": "RedemptionWarrantsTriggerPriceAxis", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "alpau_RedemptionWarrantsTriggerPriceDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redemption Warrants Trigger Price [Domain]" } } }, "localname": "RedemptionWarrantsTriggerPriceDomain", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_RelatedPartiesOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related parties offering costs.", "label": "Related Parties Offering Costs", "verboseLabel": "Related parties offering costs" } } }, "localname": "RelatedPartiesOfferingCosts", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term.", "label": "Restricted Investments Term", "verboseLabel": "Restricted Investments Term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_SecuritiesForCapitalWithClosingOfInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities for capital with closing of initial business combination.", "label": "Securities For Capital With Closing Of Initial Business Combination", "terseLabel": "Securities for capital with closing of initial business combination" } } }, "localname": "SecuritiesForCapitalWithClosingOfInitialBusinessCombination", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor.", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "verboseLabel": "Stock issuance costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "alpau_ThirdTradingDayPriorToDateOnWhichCompanyNoticeOfRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third trading day prior to date on which company notice of redemption.", "label": "Third Trading Day Prior To Date On Which Company Notice Of Redemption", "terseLabel": "Third trading day prior to date on which company notice of redemption" } } }, "localname": "ThirdTradingDayPriorToDateOnWhichCompanyNoticeOfRedemption", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting agreement.", "label": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "alpau_VolumeWeightedAveragePriceOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume weighted average price of shares.", "label": "Volume Weighted Average Price Of Shares", "verboseLabel": "Volume weighted average price of shares" } } }, "localname": "VolumeWeightedAveragePriceOfShares", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "alpau_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waiting period after which the share trading days are considered.", "label": "Waiting Period After Which The Share Trading Days Are Considered", "terseLabel": "Waiting period after which the share trading days are considered" } } }, "localname": "WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "alpau_WorkingCapitalLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loan.", "label": "Working Capital Loan [Member]" } } }, "localname": "WorkingCapitalLoanMember", "nsuri": "http://www.constellationalpha.com/20210630", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_MaximumMember": { "auth_ref": [ "r110", "r120", "r147", "r148", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r241", "r242", "r254", "r255" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r110", "r120", "r147", "r148", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r241", "r242", "r254", "r255" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r110", "r120", "r145", "r147", "r148", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r241", "r242", "r254", "r255" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r110", "r120", "r145", "r147", "r148", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r241", "r242", "r254", "r255" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued offering costs and expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r7", "r154", "r205" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r46", "r47", "r48", "r151", "r152", "r153", "r181" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Changes in current assets and current liabilities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r134", "r141" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "verboseLabel": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r42", "r79", "r81", "r84", "r88", "r95", "r96", "r97", "r99", "r100", "r101", "r102", "r103", "r104", "r106", "r107", "r167", "r171", "r184", "r203", "r205", "r229", "r235" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "verboseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]", "terseLabel": "Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r12", "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash - end of the period", "periodStartLabel": "Cash - January 21, 2021 (inception)" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net Change in Cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r3", "r38" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash Equivalents, at Carrying Value" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "verboseLabel": "FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Supplemental Disclosure of cash flow information:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r40", "r42", "r59", "r60", "r61", "r63", "r65", "r67", "r68", "r69", "r88", "r95", "r100", "r101", "r102", "r106", "r107", "r118", "r119", "r123", "r127", "r184", "r261" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperations", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r143", "r149" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Exercise price of warrant" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r17", "r93", "r231", "r238" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Commitments and Contingencies (Note 5)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r90", "r91", "r92", "r94", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments\u00a0& Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r46", "r47", "r181" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r134" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "verboseLabel": "Common Stock, Shares Subscribed but Unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r205" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r72", "r234" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "verboseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r111" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "verboseLabel": "Debt Instrument, Convertible, Warrants issued" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r109", "r112" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "verboseLabel": "Warrants issued price per warrant" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r108", "r113", "r114", "r192", "r193", "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "verboseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "verboseLabel": "Deferred underwriting commission" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r44", "r176", "r177", "r178", "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "verboseLabel": "Derivative Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r14", "r43", "r98", "r100", "r101", "r105", "r106", "r107", "r198" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "verboseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "verboseLabel": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r23", "r24", "r25", "r46", "r47", "r48", "r50", "r55", "r57", "r66", "r89", "r134", "r141", "r151", "r152", "r153", "r164", "r165", "r181", "r185", "r186", "r187", "r188", "r189", "r190", "r243", "r244", "r245", "r264" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r22", "r156", "r157", "r160", "r161", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r35" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued offerings costs and expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r11", "r42", "r88", "r184", "r205", "r230", "r237" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholder's Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "verboseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r16", "r42", "r88", "r95", "r96", "r97", "r100", "r101", "r102", "r103", "r104", "r106", "r107", "r168", "r171", "r172", "r184", "r203", "r204", "r205" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r249", "r250", "r251", "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Banking Regulation, Mortgage Banking, Net Worth, Minimum", "verboseLabel": "Minimum Net Worth Required for Compliance" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r32" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r32", "r34", "r36" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r20", "r21", "r25", "r26", "r36", "r42", "r49", "r51", "r52", "r53", "r54", "r56", "r57", "r62", "r79", "r80", "r82", "r83", "r85", "r88", "r95", "r96", "r97", "r100", "r101", "r102", "r103", "r104", "r106", "r107", "r182", "r184", "r232", "r239" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r13", "r43", "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "verboseLabel": "Note payable \u2013 related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "verboseLabel": "Formation cost" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r45", "r58", "r78", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Organization and Business Operations" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r27", "r240" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "verboseLabel": "Other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "verboseLabel": "Payments for Underwriting Expense" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r30" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payments of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r5", "r118" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r5", "r118" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r5", "r205" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from Issuance Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "verboseLabel": "Proceeds from Issuance of Private Placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r29" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "verboseLabel": "Proceeds from related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r20", "r21", "r25", "r31", "r42", "r49", "r56", "r57", "r79", "r80", "r82", "r83", "r85", "r88", "r95", "r96", "r97", "r100", "r101", "r102", "r103", "r104", "r106", "r107", "r166", "r169", "r170", "r173", "r174", "r182", "r184", "r233" ], "calculation": { "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r146", "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r146", "r197", "r198", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "verboseLabel": "Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r146", "r197", "r200", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r195", "r196", "r198", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r141", "r154", "r205", "r236", "r246", "r247" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 9.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r46", "r47", "r48", "r50", "r55", "r57", "r89", "r151", "r152", "r153", "r164", "r165", "r181", "r243", "r245" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r18", "r40", "r67", "r68", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r123", "r127", "r132", "r135", "r136", "r137", "r138", "r139", "r140", "r141" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "verboseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance (in Shares)", "periodStartLabel": "Beginning Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r39", "r45" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r4", "r5", "r6", "r40", "r42", "r59", "r60", "r61", "r63", "r65", "r67", "r68", "r69", "r88", "r95", "r100", "r101", "r102", "r106", "r107", "r118", "r119", "r123", "r127", "r134", "r184", "r261" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperations", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r19", "r23", "r24", "r25", "r46", "r47", "r48", "r50", "r55", "r57", "r66", "r89", "r134", "r141", "r151", "r152", "r153", "r164", "r165", "r181", "r185", "r186", "r187", "r188", "r189", "r190", "r243", "r244", "r245", "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperations", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r46", "r47", "r48", "r66", "r216" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementOfCashFlows", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperations", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Class\u00a0B common stock issued to Sponsor" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r5", "r6", "r134", "r141" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Stock shares issued during the period shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "verboseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r5", "r6", "r134", "r141", "r150" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r5", "r6", "r134", "r141" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "verboseLabel": "Stock Issued During Period, Shares, Stock Splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Class\u00a0B common stock issued to Sponsor (in Shares)" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r19", "r134", "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "verboseLabel": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r6", "r9", "r10", "r42", "r86", "r88", "r184", "r205" ], "calculation": { "http://www.constellationalpha.com/role/CondensedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r41", "r119", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r133", "r141", "r144" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholder's Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplit": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.", "label": "Stockholders' Equity Note, Stock Split", "verboseLabel": "Stockholders' Equity Note, Stock Split" } } }, "localname": "StockholdersEquityNoteStockSplit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r191", "r207" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r191", "r207" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r191", "r207" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.constellationalpha.com/role/CondensedBalanceSheetParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfChangesInStockholdersEquityParenthetical", "http://www.constellationalpha.com/role/CondensedStatementsOfOperationsParenthetical", "http://www.constellationalpha.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.constellationalpha.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.constellationalpha.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r155", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "verboseLabel": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "verboseLabel": "Accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r70", "r71", "r73", "r74", "r75", "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CoverPage", "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Warrants and rights outstanding term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/StockholderSEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.constellationalpha.com/role/CondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r256": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r257": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r258": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r259": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r260": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r261": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r262": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r263": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r45": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" } }, "version": "2.1" } ZIP 41 0001193125-21-271530-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-271530-xbrl.zip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end